

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 5.23208818 |
| 2 | DNA deamination (GO:0045006) | 4.77600768 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 4.41878837 |
| 4 | ribosome assembly (GO:0042255) | 4.39556818 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.97527158 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 3.83329891 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 3.77585770 |
| 8 | establishment of viral latency (GO:0019043) | 3.76974022 |
| 9 | proteasome assembly (GO:0043248) | 3.62159164 |
| 10 | cullin deneddylation (GO:0010388) | 3.61247492 |
| 11 | protein deneddylation (GO:0000338) | 3.58581397 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.57281290 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.55505474 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.51055630 |
| 15 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.49524041 |
| 16 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.45246169 |
| 17 | regulation of mitochondrial translation (GO:0070129) | 3.39885838 |
| 18 | cotranslational protein targeting to membrane (GO:0006613) | 3.39506590 |
| 19 | protein targeting to ER (GO:0045047) | 3.38286060 |
| 20 | mitotic metaphase plate congression (GO:0007080) | 3.37612698 |
| 21 | rRNA modification (GO:0000154) | 3.37124811 |
| 22 | heme biosynthetic process (GO:0006783) | 3.36019609 |
| 23 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.34253807 |
| 24 | termination of RNA polymerase III transcription (GO:0006386) | 3.34253807 |
| 25 | heme metabolic process (GO:0042168) | 3.32658447 |
| 26 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.32235883 |
| 27 | CENP-A containing nucleosome assembly (GO:0034080) | 3.32054625 |
| 28 | protein localization to endoplasmic reticulum (GO:0070972) | 3.31540360 |
| 29 | aldehyde catabolic process (GO:0046185) | 3.23852445 |
| 30 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.19693440 |
| 31 | regulation of ligase activity (GO:0051340) | 3.19640322 |
| 32 | ATP synthesis coupled proton transport (GO:0015986) | 3.14867818 |
| 33 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.14867818 |
| 34 | ventricular cardiac muscle cell development (GO:0055015) | 3.14843977 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.13476852 |
| 36 | chromatin remodeling at centromere (GO:0031055) | 3.13198473 |
| 37 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.12544463 |
| 38 | protein neddylation (GO:0045116) | 3.11078517 |
| 39 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.08495916 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06554467 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06554467 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.04175501 |
| 43 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.01881822 |
| 44 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.01881822 |
| 45 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.98459640 |
| 46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.97518728 |
| 47 | protein retention in ER lumen (GO:0006621) | 2.95447616 |
| 48 | L-methionine salvage (GO:0071267) | 2.94390878 |
| 49 | L-methionine biosynthetic process (GO:0071265) | 2.94390878 |
| 50 | amino acid salvage (GO:0043102) | 2.94390878 |
| 51 | regulation of metalloenzyme activity (GO:0048552) | 2.94032048 |
| 52 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.93486802 |
| 53 | metaphase plate congression (GO:0051310) | 2.93058853 |
| 54 | formation of translation preinitiation complex (GO:0001731) | 2.90978550 |
| 55 | viral transcription (GO:0019083) | 2.88311367 |
| 56 | purine-containing compound salvage (GO:0043101) | 2.87693613 |
| 57 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.87336018 |
| 58 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.87336018 |
| 59 | tRNA aminoacylation for protein translation (GO:0006418) | 2.86754900 |
| 60 | translational termination (GO:0006415) | 2.86498578 |
| 61 | negative regulation of protein ubiquitination (GO:0031397) | 2.86253613 |
| 62 | establishment of protein localization to mitochondrion (GO:0072655) | 2.85641180 |
| 63 | maturation of SSU-rRNA (GO:0030490) | 2.83837534 |
| 64 | respiratory electron transport chain (GO:0022904) | 2.82483567 |
| 65 | protein localization to mitochondrion (GO:0070585) | 2.82474592 |
| 66 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.82177990 |
| 67 | ribosomal small subunit biogenesis (GO:0042274) | 2.82147709 |
| 68 | rRNA methylation (GO:0031167) | 2.81808657 |
| 69 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.81223901 |
| 70 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.81223901 |
| 71 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.81223901 |
| 72 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.80424732 |
| 73 | cell cycle G1/S phase transition (GO:0044843) | 2.80424732 |
| 74 | translation (GO:0006412) | 2.80132413 |
| 75 | Golgi transport vesicle coating (GO:0048200) | 2.80028914 |
| 76 | COPI coating of Golgi vesicle (GO:0048205) | 2.80028914 |
| 77 | tRNA aminoacylation (GO:0043039) | 2.78981902 |
| 78 | amino acid activation (GO:0043038) | 2.78981902 |
| 79 | respiratory chain complex IV assembly (GO:0008535) | 2.77934193 |
| 80 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.77097419 |
| 81 | negative regulation of ligase activity (GO:0051352) | 2.77097419 |
| 82 | electron transport chain (GO:0022900) | 2.75587954 |
| 83 | type B pancreatic cell proliferation (GO:0044342) | 2.74982354 |
| 84 | regulation of protein heterodimerization activity (GO:0043497) | 2.74383462 |
| 85 | regulation of mitotic spindle organization (GO:0060236) | 2.74381408 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.72687529 |
| 87 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.70053518 |
| 88 | extracellular fibril organization (GO:0043206) | 2.69890207 |
| 89 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.69865452 |
| 90 | protein complex biogenesis (GO:0070271) | 2.69748130 |
| 91 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.69097867 |
| 92 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.69097867 |
| 93 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.68830885 |
| 94 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.67338137 |
| 95 | 7-methylguanosine mRNA capping (GO:0006370) | 2.67304260 |
| 96 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.67013116 |
| 97 | histone exchange (GO:0043486) | 2.66973154 |
| 98 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.66949278 |
| 99 | cofactor catabolic process (GO:0051187) | 2.66255140 |
| 100 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.66080936 |
| 101 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.65212729 |
| 102 | protein maturation by protein folding (GO:0022417) | 2.64735173 |
| 103 | L-serine metabolic process (GO:0006563) | 2.64286644 |
| 104 | positive regulation of actin filament depolymerization (GO:0030836) | 2.64081281 |
| 105 | peptidyl-histidine modification (GO:0018202) | 2.63307361 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63195887 |
| 107 | maturation of 5.8S rRNA (GO:0000460) | 2.63053494 |
| 108 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.62668540 |
| 109 | translational elongation (GO:0006414) | 2.62173628 |
| 110 | regulation of spindle organization (GO:0090224) | 2.61407004 |
| 111 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.60918376 |
| 112 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.60791922 |
| 113 | neutrophil activation involved in immune response (GO:0002283) | 2.59857144 |
| 114 | 7-methylguanosine RNA capping (GO:0009452) | 2.58730335 |
| 115 | RNA capping (GO:0036260) | 2.58730335 |
| 116 | proline biosynthetic process (GO:0006561) | 2.57085359 |
| 117 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.56732723 |
| 118 | IMP biosynthetic process (GO:0006188) | 2.56540182 |
| 119 | response to interferon-beta (GO:0035456) | 2.56248931 |
| 120 | termination of RNA polymerase I transcription (GO:0006363) | 2.53508564 |
| 121 | GDP-mannose metabolic process (GO:0019673) | 2.51263975 |
| 122 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.51004411 |
| 123 | purine nucleotide salvage (GO:0032261) | 2.50990464 |
| 124 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50793252 |
| 125 | cellular response to interferon-beta (GO:0035458) | 2.49204322 |
| 126 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.47685683 |
| 127 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.45191593 |
| 128 | porphyrin-containing compound metabolic process (GO:0006778) | 2.42566615 |
| 129 | translational initiation (GO:0006413) | 2.42489186 |
| 130 | telomere maintenance via recombination (GO:0000722) | 2.42419462 |
| 131 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.40423665 |
| 132 | serine family amino acid biosynthetic process (GO:0009070) | 2.38885367 |
| 133 | protein targeting to membrane (GO:0006612) | 2.38534344 |
| 134 | AMP metabolic process (GO:0046033) | 2.36596510 |
| 135 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.36350460 |
| 136 | protein autoprocessing (GO:0016540) | 2.35187520 |
| 137 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.34963327 |
| 138 | mitochondrial calcium ion transport (GO:0006851) | 2.33725976 |
| 139 | ribosomal large subunit biogenesis (GO:0042273) | 2.32625520 |
| 140 | nucleoside salvage (GO:0043174) | 2.31934417 |
| 141 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.31809684 |
| 142 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.30364727 |
| 143 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.29763734 |
| 144 | pseudouridine synthesis (GO:0001522) | 2.29154309 |
| 145 | membrane raft organization (GO:0031579) | 2.28887400 |
| 146 | respiratory burst (GO:0045730) | 2.28092264 |
| 147 | viral life cycle (GO:0019058) | 2.27963039 |
| 148 | DNA strand elongation (GO:0022616) | 2.27122594 |
| 149 | regulation of cellular amine metabolic process (GO:0033238) | 2.26964906 |
| 150 | positive regulation of cell cycle arrest (GO:0071158) | 2.26433067 |
| 151 | positive regulation of ligase activity (GO:0051351) | 2.24763152 |
| 152 | complement activation, classical pathway (GO:0006958) | 2.23079186 |
| 153 | positive regulation of macrophage differentiation (GO:0045651) | 2.21938945 |
| 154 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.20782223 |
| 155 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.19882949 |
| 156 | protein targeting to mitochondrion (GO:0006626) | 2.19059125 |
| 157 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.18603851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.96925747 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.20754994 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.16618870 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.12059083 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.02383157 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.96379331 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.78837412 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65881944 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.62970385 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.57114792 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.53341840 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.51235200 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.48625976 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.39393902 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31389774 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.28157586 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20813911 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.09765152 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.06566691 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.03921374 |
| 21 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.00698749 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00269855 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.99302118 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.92489477 |
| 25 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.90420951 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87946995 |
| 27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84790216 |
| 28 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.83004034 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79047332 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.75962347 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74053899 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73878708 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72657277 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.68024833 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65783514 |
| 36 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65474474 |
| 37 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.63707587 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.62568003 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61711509 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.59173603 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57092410 |
| 42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.56708708 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.56202376 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56043914 |
| 45 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.55100874 |
| 46 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54898527 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54541414 |
| 48 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.54471617 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54276839 |
| 50 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.54185608 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52786786 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51143470 |
| 53 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50863024 |
| 54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50571918 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48987216 |
| 56 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.47786088 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47318271 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46148522 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44821177 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44650780 |
| 61 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41478060 |
| 62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40102677 |
| 63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.39989527 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.37586814 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37482588 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36842129 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35251632 |
| 68 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.33156033 |
| 69 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.32352640 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.31725296 |
| 71 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.31599743 |
| 72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.30385851 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28569892 |
| 74 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.27477437 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27053252 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25058586 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25038736 |
| 78 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.24571623 |
| 79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24295572 |
| 80 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23838951 |
| 81 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23398197 |
| 82 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.23208099 |
| 83 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.20790154 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.19785625 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19595313 |
| 86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17704123 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17427025 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17422703 |
| 89 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17383468 |
| 90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.16927581 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16877014 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16793437 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16647118 |
| 94 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16399343 |
| 95 | MYB_26560356_Chip-Seq_TH2_Human | 1.15752559 |
| 96 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.14712783 |
| 97 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.14020270 |
| 98 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.12310413 |
| 99 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.12199878 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09305633 |
| 101 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08023916 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06246184 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06148730 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06089672 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04715206 |
| 106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04064544 |
| 107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03783396 |
| 108 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.03504132 |
| 109 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.02028712 |
| 110 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01124044 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00394311 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 1.00271489 |
| 113 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00035585 |
| 114 | MAF_26560356_Chip-Seq_TH1_Human | 0.99791569 |
| 115 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.99390296 |
| 116 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.99006268 |
| 117 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98883286 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98539890 |
| 119 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98078211 |
| 120 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97862689 |
| 121 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96938525 |
| 122 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96670902 |
| 123 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.96651749 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96472778 |
| 125 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96454928 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96388767 |
| 127 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95755867 |
| 128 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.95644561 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95439880 |
| 130 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95408013 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93953143 |
| 132 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93719483 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91764328 |
| 134 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91420436 |
| 135 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88930834 |
| 136 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86803495 |
| 137 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86803495 |
| 138 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85017485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.33950828 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.56287205 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.36441369 |
| 4 | MP0003941_abnormal_skin_development | 3.21373788 |
| 5 | MP0004272_abnormal_basement_membrane | 3.17910331 |
| 6 | MP0003186_abnormal_redox_activity | 3.09920853 |
| 7 | MP0003718_maternal_effect | 2.82128481 |
| 8 | MP0008058_abnormal_DNA_repair | 2.63486785 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.59869576 |
| 10 | MP0006054_spinal_hemorrhage | 2.44075942 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.39493861 |
| 12 | MP0003436_decreased_susceptibility_to | 2.30283762 |
| 13 | MP0003786_premature_aging | 2.30091243 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.24213752 |
| 15 | MP0003724_increased_susceptibility_to | 2.23493836 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.23424112 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.19263765 |
| 18 | MP0002933_joint_inflammation | 2.15366121 |
| 19 | MP0005083_abnormal_biliary_tract | 2.13461759 |
| 20 | MP0009785_altered_susceptibility_to | 2.05317293 |
| 21 | MP0005671_abnormal_response_to | 2.04945981 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.99831382 |
| 23 | MP0003077_abnormal_cell_cycle | 1.96699376 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.93157026 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.83643034 |
| 26 | MP0000685_abnormal_immune_system | 1.80931801 |
| 27 | MP0003195_calcinosis | 1.78453762 |
| 28 | MP0005025_abnormal_response_to | 1.73223113 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.71638685 |
| 30 | MP0009840_abnormal_foam_cell | 1.71340011 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.69595442 |
| 32 | MP0005275_abnormal_skin_tensile | 1.65126774 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.63583032 |
| 34 | MP0002419_abnormal_innate_immunity | 1.63140756 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.60254807 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.57520707 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.56245850 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.52736424 |
| 39 | MP0002723_abnormal_immune_serum | 1.52524621 |
| 40 | MP0001853_heart_inflammation | 1.52259225 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.50240620 |
| 42 | MP0001542_abnormal_bone_strength | 1.50033732 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.49915420 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.48070264 |
| 45 | MP0001800_abnormal_humoral_immune | 1.47732785 |
| 46 | MP0006082_CNS_inflammation | 1.46670231 |
| 47 | MP0002166_altered_tumor_susceptibility | 1.46666212 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.45688669 |
| 49 | MP0004147_increased_porphyrin_level | 1.44954574 |
| 50 | MP0002405_respiratory_system_inflammati | 1.44547527 |
| 51 | MP0000343_altered_response_to | 1.43930198 |
| 52 | MP0008469_abnormal_protein_level | 1.41924698 |
| 53 | MP0005360_urolithiasis | 1.41845483 |
| 54 | MP0005395_other_phenotype | 1.39514593 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.38050632 |
| 56 | MP0002006_tumorigenesis | 1.35980036 |
| 57 | MP0001819_abnormal_immune_cell | 1.35503604 |
| 58 | MP0000858_altered_metastatic_potential | 1.35159603 |
| 59 | MP0001790_abnormal_immune_system | 1.34838568 |
| 60 | MP0005387_immune_system_phenotype | 1.34838568 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.34268082 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.32219844 |
| 63 | MP0002398_abnormal_bone_marrow | 1.31948395 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.31689711 |
| 65 | MP0009764_decreased_sensitivity_to | 1.29114221 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.27987365 |
| 67 | MP0001243_abnormal_dermal_layer | 1.27358566 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.26910793 |
| 69 | MP0003279_aneurysm | 1.26213181 |
| 70 | MP0005330_cardiomyopathy | 1.26043952 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.24574465 |
| 72 | MP0008057_abnormal_DNA_replication | 1.24296206 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.23744436 |
| 74 | MP0001730_embryonic_growth_arrest | 1.23539147 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.22152622 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 1.21538549 |
| 77 | MP0005023_abnormal_wound_healing | 1.21455986 |
| 78 | MP0001545_abnormal_hematopoietic_system | 1.21018172 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 1.21018172 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 1.20914629 |
| 81 | MP0000716_abnormal_immune_system | 1.20017433 |
| 82 | MP0000762_abnormal_tongue_morphology | 1.19657414 |
| 83 | MP0000350_abnormal_cell_proliferation | 1.19213931 |
| 84 | MP0005365_abnormal_bile_salt | 1.19119348 |
| 85 | MP0000751_myopathy | 1.16939139 |
| 86 | MP0002722_abnormal_immune_system | 1.16873579 |
| 87 | MP0005508_abnormal_skeleton_morphology | 1.16662068 |
| 88 | MP0002429_abnormal_blood_cell | 1.16313449 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 1.15504969 |
| 90 | MP0001661_extended_life_span | 1.15197898 |
| 91 | MP0009384_cardiac_valve_regurgitation | 1.14398869 |
| 92 | MP0001666_abnormal_nutrient_absorption | 1.10005802 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 1.09970646 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 1.07455418 |
| 95 | MP0005501_abnormal_skin_physiology | 1.06878826 |
| 96 | MP0001958_emphysema | 1.05504070 |
| 97 | MP0004947_skin_inflammation | 1.03474502 |
| 98 | MP0005390_skeleton_phenotype | 1.02406441 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 1.01670275 |
| 100 | MP0005332_abnormal_amino_acid | 1.01315097 |
| 101 | MP0000490_abnormal_crypts_of | 0.99433923 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.98913311 |
| 103 | MP0002938_white_spotting | 0.98077070 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.97658330 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.97508160 |
| 106 | MP0001697_abnormal_embryo_size | 0.97292073 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97063755 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.96529814 |
| 109 | MP0009763_increased_sensitivity_to | 0.94945289 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.94709281 |
| 111 | MP0001764_abnormal_homeostasis | 0.94436115 |
| 112 | MP0000609_abnormal_liver_physiology | 0.93404661 |
| 113 | MP0002132_abnormal_respiratory_system | 0.92120493 |
| 114 | MP0010155_abnormal_intestine_physiology | 0.91604889 |
| 115 | MP0002019_abnormal_tumor_incidence | 0.91191093 |
| 116 | MP0002080_prenatal_lethality | 0.90579530 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.89851938 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.89408676 |
| 119 | MP0005380_embryogenesis_phenotype | 0.89408676 |
| 120 | MP0001881_abnormal_mammary_gland | 0.89221124 |
| 121 | MP0009697_abnormal_copulation | 0.88301079 |
| 122 | MP0002160_abnormal_reproductive_system | 0.88019213 |
| 123 | MP0009250_abnormal_appendicular_skeleto | 0.87770871 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.87612442 |
| 125 | MP0000516_abnormal_urinary_system | 0.86954303 |
| 126 | MP0005367_renal/urinary_system_phenotyp | 0.86954303 |
| 127 | MP0001529_abnormal_vocalization | 0.86823175 |
| 128 | MP0002282_abnormal_trachea_morphology | 0.86624404 |
| 129 | MP0003795_abnormal_bone_structure | 0.86285590 |
| 130 | MP0002108_abnormal_muscle_morphology | 0.85470269 |
| 131 | MP0000749_muscle_degeneration | 0.85178367 |
| 132 | MP0003448_altered_tumor_morphology | 0.85003226 |
| 133 | MP0008789_abnormal_olfactory_epithelium | 0.83686849 |
| 134 | MP0005408_hypopigmentation | 0.83389290 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.82888538 |
| 136 | MP0003950_abnormal_plasma_membrane | 0.82667647 |
| 137 | MP0000598_abnormal_liver_morphology | 0.82524998 |
| 138 | MP0010234_abnormal_vibrissa_follicle | 0.81454341 |
| 139 | MP0000358_abnormal_cell_content/ | 0.81438283 |
| 140 | MP0002295_abnormal_pulmonary_circulatio | 0.81176049 |
| 141 | MP0008875_abnormal_xenobiotic_pharmacok | 0.80426501 |
| 142 | MP0005165_increased_susceptibility_to | 0.79286848 |
| 143 | MP0003984_embryonic_growth_retardation | 0.78798374 |
| 144 | MP0002254_reproductive_system_inflammat | 0.78560906 |
| 145 | MP0002060_abnormal_skin_morphology | 0.78297252 |
| 146 | MP0002796_impaired_skin_barrier | 0.76946728 |
| 147 | MP0008873_increased_physiological_sensi | 0.76846170 |
| 148 | MP0010771_integument_phenotype | 0.75248520 |
| 149 | MP0005451_abnormal_body_composition | 0.75081195 |
| 150 | MP0002088_abnormal_embryonic_growth/wei | 0.74753012 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.74740940 |
| 152 | MP0002084_abnormal_developmental_patter | 0.74510683 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.73735672 |
| 154 | MP0002085_abnormal_embryonic_tissue | 0.71878940 |
| 155 | MP0010307_abnormal_tumor_latency | 0.70616147 |
| 156 | MP0004215_abnormal_myocardial_fiber | 0.70275072 |
| 157 | MP0000313_abnormal_cell_death | 0.68051030 |
| 158 | MP0000013_abnormal_adipose_tissue | 0.67920731 |
| 159 | MP0000750_abnormal_muscle_regeneration | 0.67530448 |
| 160 | MP0005384_cellular_phenotype | 0.65992344 |
| 161 | MP0002210_abnormal_sex_determination | 0.65278605 |
| 162 | MP0002269_muscular_atrophy | 0.64856249 |
| 163 | MP0009053_abnormal_anal_canal | 0.62128879 |
| 164 | MP0002086_abnormal_extraembryonic_tissu | 0.61336215 |
| 165 | MP0002177_abnormal_outer_ear | 0.59786586 |
| 166 | MP0005621_abnormal_cell_physiology | 0.58998733 |
| 167 | MP0010386_abnormal_urinary_bladder | 0.58924954 |
| 168 | MP0003937_abnormal_limbs/digits/tail_de | 0.58066022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.63641560 |
| 2 | Progressive macrocephaly (HP:0004481) | 3.38209709 |
| 3 | Vertebral compression fractures (HP:0002953) | 3.33614399 |
| 4 | Beaking of vertebral bodies (HP:0004568) | 3.09041282 |
| 5 | Irregular epiphyses (HP:0010582) | 3.01573801 |
| 6 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.00547430 |
| 7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00366964 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 2.95186332 |
| 9 | Rough bone trabeculation (HP:0100670) | 2.95153584 |
| 10 | Abnormal gallbladder physiology (HP:0012438) | 2.91390248 |
| 11 | Cholecystitis (HP:0001082) | 2.91390248 |
| 12 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.90796995 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89763889 |
| 14 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.87190989 |
| 15 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.87190989 |
| 16 | Increased serum pyruvate (HP:0003542) | 2.86809726 |
| 17 | Entropion (HP:0000621) | 2.82949335 |
| 18 | Protrusio acetabuli (HP:0003179) | 2.79953467 |
| 19 | Ankle contracture (HP:0006466) | 2.72081862 |
| 20 | Aortic dissection (HP:0002647) | 2.71089168 |
| 21 | Petechiae (HP:0000967) | 2.69298549 |
| 22 | Cerebral edema (HP:0002181) | 2.68035733 |
| 23 | Renal Fanconi syndrome (HP:0001994) | 2.65476363 |
| 24 | Hepatic necrosis (HP:0002605) | 2.64900174 |
| 25 | Hepatocellular necrosis (HP:0001404) | 2.64083464 |
| 26 | Abnormality of glycolysis (HP:0004366) | 2.62172012 |
| 27 | Testicular atrophy (HP:0000029) | 2.61860110 |
| 28 | Poor head control (HP:0002421) | 2.60266788 |
| 29 | IgM deficiency (HP:0002850) | 2.57131978 |
| 30 | Palpitations (HP:0001962) | 2.56103676 |
| 31 | Follicular hyperkeratosis (HP:0007502) | 2.52446742 |
| 32 | Soft skin (HP:0000977) | 2.48822806 |
| 33 | Abnormal tarsal ossification (HP:0008369) | 2.47763638 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.44006994 |
| 35 | Abnormality of dentin (HP:0010299) | 2.43382504 |
| 36 | Sparse eyelashes (HP:0000653) | 2.42198475 |
| 37 | Exercise intolerance (HP:0003546) | 2.41854955 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.41626013 |
| 39 | Premature rupture of membranes (HP:0001788) | 2.39904030 |
| 40 | Increased serum ferritin (HP:0003281) | 2.37855023 |
| 41 | Reduced antithrombin III activity (HP:0001976) | 2.36507544 |
| 42 | Abnormality of the umbilical cord (HP:0010881) | 2.35069737 |
| 43 | Microglossia (HP:0000171) | 2.35014775 |
| 44 | Type I transferrin isoform profile (HP:0003642) | 2.34407199 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.29023954 |
| 46 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27347456 |
| 47 | Nonimmune hydrops fetalis (HP:0001790) | 2.23576035 |
| 48 | Chronic otitis media (HP:0000389) | 2.22810433 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.22200237 |
| 50 | Oral leukoplakia (HP:0002745) | 2.21761831 |
| 51 | Joint stiffness (HP:0001387) | 2.21375945 |
| 52 | Atrophic scars (HP:0001075) | 2.20938470 |
| 53 | Trismus (HP:0000211) | 2.20523094 |
| 54 | Vascular tortuosity (HP:0004948) | 2.19834988 |
| 55 | Purpura (HP:0000979) | 2.19190364 |
| 56 | Short middle phalanx of the 5th finger (HP:0004220) | 2.17749688 |
| 57 | Aplastic anemia (HP:0001915) | 2.17527563 |
| 58 | Abnormality of placental membranes (HP:0011409) | 2.17173290 |
| 59 | Amniotic constriction ring (HP:0009775) | 2.17173290 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.15421298 |
| 61 | Aortic aneurysm (HP:0004942) | 2.15196293 |
| 62 | Secondary amenorrhea (HP:0000869) | 2.14990788 |
| 63 | Cervical subluxation (HP:0003308) | 2.14800932 |
| 64 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14561891 |
| 65 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.13809350 |
| 66 | Sensory axonal neuropathy (HP:0003390) | 2.13575731 |
| 67 | Respiratory failure (HP:0002878) | 2.12535918 |
| 68 | Abnormal hemoglobin (HP:0011902) | 2.11880845 |
| 69 | B lymphocytopenia (HP:0010976) | 2.11838606 |
| 70 | Abnormality of B cell number (HP:0010975) | 2.11838606 |
| 71 | Glucose intolerance (HP:0000833) | 2.11764316 |
| 72 | Abnormal delivery (HP:0001787) | 2.11064014 |
| 73 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10720288 |
| 74 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10720288 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.10720288 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.10720288 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.09968908 |
| 78 | Fragile skin (HP:0001030) | 2.06205426 |
| 79 | Exertional dyspnea (HP:0002875) | 2.05642789 |
| 80 | Steatorrhea (HP:0002570) | 2.03154144 |
| 81 | Abnormal trabecular bone morphology (HP:0100671) | 2.02616499 |
| 82 | Increased CSF lactate (HP:0002490) | 2.02518388 |
| 83 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02287491 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.01762766 |
| 85 | Cupped ribs (HP:0000887) | 2.01686579 |
| 86 | Biconcave vertebral bodies (HP:0004586) | 2.01634466 |
| 87 | Abnormal foot bone ossification (HP:0010675) | 2.00953228 |
| 88 | Recurrent abscess formation (HP:0002722) | 2.00878041 |
| 89 | Epiphyseal dysplasia (HP:0002656) | 1.99960884 |
| 90 | Degeneration of anterior horn cells (HP:0002398) | 1.99769105 |
| 91 | Abnormality of the anterior horn cell (HP:0006802) | 1.99769105 |
| 92 | Opisthotonus (HP:0002179) | 1.99113205 |
| 93 | Peritonitis (HP:0002586) | 1.97807209 |
| 94 | Autoamputation (HP:0001218) | 1.97783552 |
| 95 | Spinal rigidity (HP:0003306) | 1.96443592 |
| 96 | Thrombocytosis (HP:0001894) | 1.96050314 |
| 97 | Cerebral hypomyelination (HP:0006808) | 1.95895067 |
| 98 | Increased serum lactate (HP:0002151) | 1.94598487 |
| 99 | Axonal loss (HP:0003447) | 1.93995159 |
| 100 | Microcytic anemia (HP:0001935) | 1.93481059 |
| 101 | Microvesicular hepatic steatosis (HP:0001414) | 1.92429372 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 1.91652118 |
| 103 | Adrenal hypoplasia (HP:0000835) | 1.91066619 |
| 104 | Increased hepatocellular lipid droplets (HP:0006565) | 1.90486516 |
| 105 | Breech presentation (HP:0001623) | 1.89978733 |
| 106 | Acute necrotizing encephalopathy (HP:0006965) | 1.89650854 |
| 107 | Coxa vara (HP:0002812) | 1.89504674 |
| 108 | Myocardial infarction (HP:0001658) | 1.88842920 |
| 109 | Congenital, generalized hypertrichosis (HP:0004540) | 1.88096063 |
| 110 | Cardiovascular calcification (HP:0011915) | 1.87180014 |
| 111 | Hepatosplenomegaly (HP:0001433) | 1.86660701 |
| 112 | Delayed gross motor development (HP:0002194) | 1.86198068 |
| 113 | Elbow flexion contracture (HP:0002987) | 1.86008701 |
| 114 | Wormian bones (HP:0002645) | 1.85939389 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85929410 |
| 116 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.85783227 |
| 117 | Methylmalonic acidemia (HP:0002912) | 1.85189993 |
| 118 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.85049178 |
| 119 | Metaphyseal dysplasia (HP:0100255) | 1.84888310 |
| 120 | Abnormality of methionine metabolism (HP:0010901) | 1.84803235 |
| 121 | Protuberant abdomen (HP:0001538) | 1.84574220 |
| 122 | Abnormality of T cells (HP:0002843) | 1.84285466 |
| 123 | Recurrent bacterial skin infections (HP:0005406) | 1.84177208 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83220280 |
| 125 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.82878477 |
| 126 | Single umbilical artery (HP:0001195) | 1.82878477 |
| 127 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.82878477 |
| 128 | Acute encephalopathy (HP:0006846) | 1.82864963 |
| 129 | Vascular calcification (HP:0004934) | 1.82745406 |
| 130 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.82619696 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.82529913 |
| 132 | Xanthomatosis (HP:0000991) | 1.81962282 |
| 133 | Redundant skin (HP:0001582) | 1.81904611 |
| 134 | Nausea (HP:0002018) | 1.81875939 |
| 135 | Abnormal spermatogenesis (HP:0008669) | 1.81238012 |
| 136 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79983809 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.79973504 |
| 138 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.79518076 |
| 139 | Osteolytic defects of the hand bones (HP:0009699) | 1.79187417 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79187417 |
| 141 | Lactic acidosis (HP:0003128) | 1.78713113 |
| 142 | Generalized amyotrophy (HP:0003700) | 1.78589763 |
| 143 | Macrocytic anemia (HP:0001972) | 1.78282404 |
| 144 | Irregular vertebral endplates (HP:0003301) | 1.77715041 |
| 145 | Interstitial pulmonary disease (HP:0006530) | 1.77692786 |
| 146 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76473589 |
| 147 | Short nail (HP:0001799) | 1.76389486 |
| 148 | Myositis (HP:0100614) | 1.75932775 |
| 149 | Upper limb muscle weakness (HP:0003484) | 1.75441313 |
| 150 | T lymphocytopenia (HP:0005403) | 1.74987263 |
| 151 | Hypergammaglobulinemia (HP:0010702) | 1.74319802 |
| 152 | Hypokinesia (HP:0002375) | 1.73532455 |
| 153 | Abnormal gallbladder morphology (HP:0012437) | 1.72839730 |
| 154 | Multiple enchondromatosis (HP:0005701) | 1.72636018 |
| 155 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.72469697 |
| 156 | Arterial tortuosity (HP:0005116) | 1.72384344 |
| 157 | Abnormality of T cell number (HP:0011839) | 1.72255996 |
| 158 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.71349911 |
| 159 | Abnormality of the common coagulation pathway (HP:0010990) | 1.70670151 |
| 160 | Onycholysis (HP:0001806) | 1.70476453 |
| 161 | Cholelithiasis (HP:0001081) | 1.70024509 |
| 162 | Erythema (HP:0010783) | 1.69575408 |
| 163 | Diaphragmatic weakness (HP:0009113) | 1.69570027 |
| 164 | Pallor (HP:0000980) | 1.69528556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.72789414 |
| 2 | EIF2AK1 | 3.96083620 |
| 3 | VRK2 | 3.78230537 |
| 4 | PIM2 | 3.11129837 |
| 5 | TESK2 | 3.07734376 |
| 6 | NEK1 | 3.02754730 |
| 7 | ERN1 | 2.81684044 |
| 8 | KDR | 2.73523236 |
| 9 | EIF2AK3 | 2.46027357 |
| 10 | MAP4K1 | 2.38071923 |
| 11 | BLK | 2.35446028 |
| 12 | PBK | 2.35282650 |
| 13 | ZAP70 | 2.11682413 |
| 14 | TESK1 | 2.10989194 |
| 15 | STK16 | 2.08322425 |
| 16 | TTK | 2.04781805 |
| 17 | MAP3K11 | 2.02629084 |
| 18 | SCYL2 | 1.98927421 |
| 19 | PLK3 | 1.93112643 |
| 20 | BCKDK | 1.92066394 |
| 21 | BUB1 | 1.90969392 |
| 22 | TSSK6 | 1.90054958 |
| 23 | PAK4 | 1.82095555 |
| 24 | TBK1 | 1.81089155 |
| 25 | LIMK1 | 1.80274727 |
| 26 | SRPK1 | 1.70778313 |
| 27 | NUAK1 | 1.68451882 |
| 28 | MST4 | 1.63146842 |
| 29 | JAK3 | 1.46011511 |
| 30 | IRAK4 | 1.38053033 |
| 31 | ABL2 | 1.37808432 |
| 32 | NEK9 | 1.36823848 |
| 33 | EPHA2 | 1.32034768 |
| 34 | PIK3CG | 1.28810597 |
| 35 | MAPKAPK3 | 1.25933955 |
| 36 | LRRK2 | 1.23443409 |
| 37 | TAF1 | 1.20852587 |
| 38 | PTK2 | 1.20714537 |
| 39 | MAPKAPK5 | 1.19831632 |
| 40 | RPS6KA4 | 1.19823213 |
| 41 | MAP3K14 | 1.18855081 |
| 42 | PLK1 | 1.17161824 |
| 43 | TRPM7 | 1.15626648 |
| 44 | MAP2K3 | 1.13406921 |
| 45 | FLT3 | 1.12663469 |
| 46 | BRSK1 | 1.12065037 |
| 47 | MAP3K3 | 1.11884935 |
| 48 | TXK | 1.09342351 |
| 49 | EPHB1 | 1.08528345 |
| 50 | TYK2 | 1.07816237 |
| 51 | ERBB4 | 1.07020099 |
| 52 | NME1 | 1.03411975 |
| 53 | ZAK | 1.01388028 |
| 54 | IKBKE | 0.97888336 |
| 55 | TEC | 0.97498728 |
| 56 | IRAK3 | 0.96805200 |
| 57 | CLK1 | 0.92775631 |
| 58 | MST1R | 0.91826874 |
| 59 | ACVR1B | 0.91036611 |
| 60 | NLK | 0.89611751 |
| 61 | DAPK1 | 0.87180517 |
| 62 | ARAF | 0.87048072 |
| 63 | ILK | 0.84544940 |
| 64 | TRIM28 | 0.80357590 |
| 65 | BRAF | 0.80225207 |
| 66 | KIT | 0.79734953 |
| 67 | STK10 | 0.79475946 |
| 68 | MYLK | 0.79157976 |
| 69 | CDK8 | 0.77924137 |
| 70 | TRIB3 | 0.75678110 |
| 71 | PRKG2 | 0.75300005 |
| 72 | VRK1 | 0.75281019 |
| 73 | TGFBR2 | 0.75258309 |
| 74 | IRAK1 | 0.74893438 |
| 75 | STK3 | 0.74274393 |
| 76 | NEK2 | 0.73843575 |
| 77 | IKBKB | 0.73022675 |
| 78 | EIF2AK2 | 0.71681287 |
| 79 | FER | 0.71126261 |
| 80 | PIM1 | 0.70702831 |
| 81 | SYK | 0.70487690 |
| 82 | PAK2 | 0.69949022 |
| 83 | BRSK2 | 0.68964610 |
| 84 | BMPR1B | 0.68545453 |
| 85 | PLK2 | 0.67446246 |
| 86 | ERBB3 | 0.66860244 |
| 87 | MUSK | 0.66190546 |
| 88 | CDC7 | 0.63762603 |
| 89 | LYN | 0.63447301 |
| 90 | MAP3K8 | 0.62510140 |
| 91 | CHEK2 | 0.61936701 |
| 92 | PRKCI | 0.61277502 |
| 93 | BTK | 0.60261602 |
| 94 | MOS | 0.58819526 |
| 95 | WEE1 | 0.57727144 |
| 96 | RPS6KB2 | 0.57657736 |
| 97 | LCK | 0.57412014 |
| 98 | LMTK2 | 0.56598752 |
| 99 | TLK1 | 0.56346775 |
| 100 | MAP3K5 | 0.53954307 |
| 101 | MET | 0.53157069 |
| 102 | MKNK2 | 0.52497160 |
| 103 | DMPK | 0.52206085 |
| 104 | CSF1R | 0.50915535 |
| 105 | CSNK1G1 | 0.49299586 |
| 106 | CSK | 0.48933859 |
| 107 | PAK1 | 0.48765747 |
| 108 | TIE1 | 0.48488358 |
| 109 | DDR2 | 0.48453818 |
| 110 | AURKA | 0.47848782 |
| 111 | MAPKAPK2 | 0.47718774 |
| 112 | STK38L | 0.46894324 |
| 113 | MAP4K2 | 0.44354059 |
| 114 | DAPK3 | 0.43338094 |
| 115 | CSNK1G3 | 0.43315483 |
| 116 | PLK4 | 0.43047996 |
| 117 | CHEK1 | 0.42207480 |
| 118 | TAOK3 | 0.41461717 |
| 119 | RPS6KA5 | 0.41264667 |
| 120 | JAK1 | 0.41237866 |
| 121 | PTK2B | 0.40612589 |
| 122 | ITK | 0.38707345 |
| 123 | STK39 | 0.38523748 |
| 124 | MKNK1 | 0.38082048 |
| 125 | CSNK2A1 | 0.38053517 |
| 126 | LATS1 | 0.37680130 |
| 127 | AURKB | 0.37305274 |
| 128 | ATM | 0.36985851 |
| 129 | MAP3K12 | 0.35873263 |
| 130 | ROCK1 | 0.35820258 |
| 131 | MAP2K2 | 0.35514940 |
| 132 | CDK7 | 0.35460491 |
| 133 | PRKCD | 0.35387739 |
| 134 | ATR | 0.33088151 |
| 135 | TGFBR1 | 0.32991759 |
| 136 | ROCK2 | 0.32616749 |
| 137 | CSNK1A1L | 0.32261837 |
| 138 | TAOK2 | 0.31004660 |
| 139 | PDK2 | 0.30839804 |
| 140 | TTN | 0.30278400 |
| 141 | ABL1 | 0.28971719 |
| 142 | CSNK2A2 | 0.26877612 |
| 143 | MATK | 0.26608090 |
| 144 | MAP3K6 | 0.24845710 |
| 145 | BMX | 0.24507538 |
| 146 | FGFR4 | 0.24034665 |
| 147 | DYRK2 | 0.23917822 |
| 148 | RAF1 | 0.23814583 |
| 149 | STK4 | 0.23710873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.99475683 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.98713741 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.11813664 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.65840279 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.45795592 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.11557667 |
| 7 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.08986765 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01638383 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78735024 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 1.78598002 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.78562331 |
| 12 | Basal transcription factors_Homo sapiens_hsa03022 | 1.77732848 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.72482834 |
| 14 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.64096380 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 1.55112570 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54427937 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47188807 |
| 18 | * Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.44639420 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44301551 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43641616 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.43178207 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.35841120 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.34682240 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34274372 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29942176 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28831960 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.28645993 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25706079 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23081553 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21623422 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21261933 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15542042 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13740847 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.13549037 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.10979796 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09644291 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09564658 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08716174 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05169897 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04434502 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.03545388 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02023594 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.01911125 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.00750190 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.95402698 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.94786905 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92879855 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91800760 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90656712 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88048664 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85664151 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84808903 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84542294 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.84387865 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.84051018 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84046522 |
| 57 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83797135 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83500244 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83237233 |
| 60 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82856797 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.82581894 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81826881 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81708928 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81059864 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79828948 |
| 66 | Spliceosome_Homo sapiens_hsa03040 | 0.79012189 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78835886 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.77918354 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77149697 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77123464 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75831641 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75319920 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74810441 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.73670154 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73131250 |
| 76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72110370 |
| 77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71739912 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71722656 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.69911395 |
| 80 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69762701 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.69022349 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68668764 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.68243495 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.67894201 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66872131 |
| 86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66848232 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66773809 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66743976 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.66724013 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66506117 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66353722 |
| 92 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65359750 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.64352575 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.64196997 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64184383 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64083869 |
| 97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58870266 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.58152090 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.55206168 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53146005 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52474928 |
| 102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50611518 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50543237 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49320394 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48553910 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48235819 |
| 107 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47828694 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44711772 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44448855 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43146592 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42547141 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42493844 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41976471 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41089645 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39995892 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39454619 |
| 117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39433813 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39077752 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38900480 |
| 120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38014458 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33284034 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.32323925 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28000570 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27689938 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.24043596 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23274213 |
| 127 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20686288 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20341830 |
| 129 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.19886742 |
| 130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18126299 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.17129202 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16925602 |
| 133 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16283066 |

